Clinical Trial Update: A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bemotuzumab with chemotherapy and anlotinib induction followed by consolidative thoracic radiotherapy for extensive-stage smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Bemotuzumab (bemotuzumab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Small Cell Lung Cancer (SCLC), SCLC, Extensive Stage | Phase 2 | Status: NOT_YET_RECRUITING